Examining The Effect of Blood Flow Restricted Aerobic Training on

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This parallel-arm trial study investigates the effects of restricting arterial blood flow during cycling exercise on citrate synthase. Participants will be randomized to either a blood flow restricted or non-blood flow restricted exercise training group. Both groups will complete seven, 30-minute exercise sessions over a 14-day period.

See also
Status	Clinical Trial	Phase
Completed	`NCT03717948` - Examining the Impact of Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males	N/A
Recruiting	`NCT03975777` - Time-course of Mitochondrial Biogenic Gene and Protein Expression in Exercised Human Skeletal Muscle	N/A
Terminated	`NCT01727167` - CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle	Phase 1/Phase 2

NCT number	NCT04151095
Study type	Interventional
Source	Queen's University
Contact
Status	Completed
Phase	N/A
Start date	May 6, 2019
Completion date	December 13, 2019

Examining The Effect of Blood Flow Restricted Aerobic Training on Mitochondrial Adaptations in Young Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms